Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessLincoln Electric Holdings, Inc. (NASDAQ:LECO) Quarterly Earnings Preview

Lincoln Electric Holdings, Inc. (NASDAQ:LECO) Quarterly Earnings Preview

Add to Favorite
Added to Favorite


Lincoln Electric Holdings, Inc. (NASDAQ:LECO) is a prominent player in the manufacturing sector, specializing in welding products, cutting equipment, and automation systems. As a leader in its field, LECO competes with companies like Illinois Tool Works and ESAB Corporation. The company is set to release its quarterly earnings on April 30, 2025, with Wall Street analysts estimating an earnings per share (EPS) of $2.22 and projected revenue of approximately $980 million.

Despite expectations of a year-over-year decline in earnings and lower revenues for the quarter ending March 2025, LECO is anticipated to surpass these estimates, as highlighted by Zacks Investment Research. If the actual results exceed the projections, the stock could experience an upward movement. The management’s discussion during the earnings call will be crucial in assessing the sustainability of any immediate price changes and future earnings expectations.

LECO’s financial metrics provide insight into its market valuation and operational efficiency. The company’s price-to-earnings (P/E) ratio of approximately 22.25 indicates the price investors are willing to pay for each dollar of earnings. Additionally, the price-to-sales ratio stands at about 2.58, reflecting the market’s valuation of its revenue. The enterprise value to sales ratio is around 2.82, offering a perspective on the company’s valuation relative to its sales, including debt and excluding cash.

The enterprise value to operating cash flow ratio is approximately 18.89, suggesting how well LECO can generate cash from its operations relative to its enterprise value. With an earnings yield of about 4.49%, the company offers a return on investment from its earnings. The debt-to-equity ratio is approximately 1.03, indicating the proportion of debt used to finance the company’s assets relative to shareholders’ equity. Lastly, the current ratio is about 1.87, suggesting that LECO has a good level of liquidity to cover its short-term liabilities.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Robinhood Markets, Inc. (NASDAQ: HOOD) Earnings Preview and Stock Surge

Robinhood Markets, Inc. (NASDAQ:HOOD) anticipates earnings per share of...

SpringWorks Therapeutics Acquisition by Merck KGaA

Merck KGaA plans to acquire SpringWorks Therapeutics (NASDAQ:SWTX) for...

Novartis AG (NYSE:NVS) Surpasses Earnings Estimates but Misses on Revenue

Earnings Per Share (EPS) of $2.28, beating the estimated...